Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year after Kidney Transplantation.

Marques IDB, Araújo MJCLN, Graciolli FG, Dos Reis LM, Pereira RMR, Alvarenga JC, Custódio MR, Jorgetti V, Elias RM, Moysés RMA, David-Neto E.

J Am Soc Nephrol. 2019 Jan 3. pii: ASN.2018060656. doi: 10.1681/ASN.2018060656. [Epub ahead of print]

PMID:
30606784
2.

Evaluation of a protocol for coronary artery disease investigation in asymptomatic elderly hemodialysis patients.

De Lima JJG, Gowdak LHW, de Paula FJ, Muela HCS, David-Neto E, Bortolotto LA.

Int J Nephrol Renovasc Dis. 2018 Nov 14;11:303-311. doi: 10.2147/IJNRD.S174018. eCollection 2018.

3.

Longitudinal Pharmacokinetics of Mycophenolic Acid in Elderly Renal Transplant Recipients Compared to a Younger Control Group: Data from the nEverOld Trial.

Romano P, Agena F, de Almeida Rezende Ebner P, Massakazu Sumita N, Kamada Triboni AH, Ramos F, Dos Santos Garcia M, Coelho Duarte NJ, Brambate Carvalhinho Lemos F, Zocoler Galante N, David-Neto E.

Eur J Drug Metab Pharmacokinet. 2018 Sep 18. doi: 10.1007/s13318-018-0506-6. [Epub ahead of print]

PMID:
30229398
4.

A large, international study on post-transplant glomerular diseases: the TANGO project.

Uffing A, Pérez-Sáez MJ, La Manna G, Comai G, Fischman C, Farouk S, Manfro RC, Bauer AC, Lichtenfels B, Mansur JB, Tedesco-Silva H, Kirsztajn GM, Manonelles A, Bestard O, Riella MC, Hokazono SR, Arias-Cabrales C, David-Neto E, Ventura CG, Akalin E, Mohammed O, Khankin EV, Safa K, Malvezzi P, O'Shaughnessy MM, Cheng XS, Cravedi P, Riella LV.

BMC Nephrol. 2018 Sep 12;19(1):229. doi: 10.1186/s12882-018-1025-z.

5.

Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.

Bicalho CS, Oliveira RDR, David DR, Fink MCDS, Agena F, Castro MC, Panutti C, David-Neto E, Pierrotti LC.

Transpl Infect Dis. 2018 Oct;20(5):e12969. doi: 10.1111/tid.12969. Epub 2018 Sep 3.

PMID:
30074295
6.

The Kinetics of Anti-HLA Antibodies in the First Year after Kidney Transplantation: In Whom and When Should They Be Monitored?

de Castro MCR, Barbosa EA, Souza RP, Agena F, de Souza PS, Maciel G, Rodrigues H, Panajotopoulos N, David DS, de Paula FJ, David-Neto E.

J Transplant. 2018 Apr 23;2018:8316860. doi: 10.1155/2018/8316860. eCollection 2018.

7.

Cytomegalovirus prophylaxis in seropositive renal transplant recipients receiving thymoglobulin induction therapy: Outcome and risk factors for late CMV disease.

Reusing JO Jr, Feitosa EB, Agena F, Pierrotti LC, Azevedo LSF, Kotton CN, David-Neto E.

Transpl Infect Dis. 2018 Oct;20(5):e12929. doi: 10.1111/tid.12929. Epub 2018 Jul 2.

PMID:
29809309
8.

The effect of vitamin D and zoledronic acid in bone marrow adiposity in kidney transplant patients: A post hoc analysis.

Hernandez MJ, Dos Reis LM, Marques ID, Araujo MJ, Truyts CAM, Oliveira IB, Barreto FC, David-Neto E, Custodio MR, Moyses RM, Bellorin-Font E, Jorgetti V.

PLoS One. 2018 May 25;13(5):e0197994. doi: 10.1371/journal.pone.0197994. eCollection 2018.

9.

Does the urinary tract infection caused by carbapenem-resistant Gram-negative bacilli impact the outcome of kidney transplant recipients?

Freire MP, Mendes CV, Piovesan AC, de Paula FJ, Spadão F, Nahas WC, David-Neto E, Pierrotti LC.

Transpl Infect Dis. 2018 Aug;20(4):e12923. doi: 10.1111/tid.12923. Epub 2018 Jun 13.

PMID:
29797681
10.
11.

UPLC-MS/MS assay validation for tacrolimus quantitative determination in peripheral blood T CD4+ and B CD19+ lymphocytes.

Romano P, da Luz Fernandes M, de Almeida Rezende Ebner P, Duarte de Oliveira N, Mitsue Okuda L, Agena F, Mendes ME, Massakazu Sumita N, Coelho V, David-Neto E, Zocoler Galante N.

J Pharm Biomed Anal. 2018 Apr 15;152:306-314. doi: 10.1016/j.jpba.2018.01.002. Epub 2018 Jan 5.

PMID:
29471254
12.

Persistent hyperparathyroidism as a risk factor for long-term graft failure: the need to discuss indication for parathyroidectomy.

Araujo MJCLN, Ramalho JAM, Elias RM, Jorgetti V, Nahas W, Custodio M, Moysés RMA, David-Neto E.

Surgery. 2018 May;163(5):1144-1150. doi: 10.1016/j.surg.2017.12.010. Epub 2018 Jan 10.

PMID:
29331397
13.

Cytomegalovirus infection after transplantation: prevention is still the challenge.

Reusing Junior JO, David-Neto E.

J Bras Nefrol. 2017 Oct-Dec;39(4):353-354. doi: 10.5935/0101-2800.20170064. English, Portuguese. No abstract available.

14.

First Report of Granulicatella sp. Endocarditis in a Kidney Transplant Patient.

Paula FJ, Neves PDMM, Bridi RA, Song ATW, David-Neto E.

J Bras Nefrol. 2017 Jul-Sep;39(3):341-344. doi: 10.5935/0101-2800.20170059. English, Portuguese.

15.

Chikungunya in kidney transplant recipients: A series of cases.

Pierrotti LC, Lopes MIBF, Nascimento APD, Caiaffa-Filho H, Lemos FBC, Reusing JO Jr, Sejas ONE, David-Neto E, Azevedo LS.

Int J Infect Dis. 2017 Nov;64:96-99. doi: 10.1016/j.ijid.2017.09.009. Epub 2017 Sep 21.

16.

Hypovitaminosis D in patients undergoing kidney transplant: the importance of sunlight exposure.

Vilarta CF, Unger MD, Dos Reis LM, Dominguez WV, David-Neto E, Moysés RM, Titan S, Custodio MR, Hernandez MJ, Jorgetti V.

Clinics (Sao Paulo). 2017 Jul;72(7):415-421. doi: 10.6061/clinics/2017(07)05.

17.

Anticoagulation in acute ischemic stroke: A systematic search.

Froio NL, Montgomery RM, David-Neto E, Aprahamian I.

Rev Assoc Med Bras (1992). 2017 Jan 1;63(1):50-56. doi: 10.1590/1806-9282.63.01.50. Review.

18.

Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities.

Marques ID, Araújo MJ, Graciolli FG, Reis LM, Pereira RM, Custódio MR, Jorgetti V, Elias RM, David-Neto E, Moysés RM.

Osteoporos Int. 2017 May;28(5):1675-1683. doi: 10.1007/s00198-017-3956-9. Epub 2017 Feb 16.

PMID:
28204954
19.

The Case | Unexplained fever and acute kidney injury in a kidney transplant patient.

Paula FJ, Neves PD, Lazari CS, Ramos RG, Frediani MM, Silva MV, Mfinda N, Pierrotti LC, David DS, Testagrossa LA, David-Neto E.

Kidney Int. 2016 Dec;90(6):1391-1392. doi: 10.1016/j.kint.2016.07.003. No abstract available.

PMID:
27884317
20.

Longitudinal Pharmacokinetics of Everolimus When Combined With Low-level of Tacrolimus in Elderly Renal Transplant Recipients.

David-Neto E, Agena F, Ramos F, Triboni AHK, Romano P, de Almeida Rezende Ebner P, Coelho V, Galante NZ, Lemos FBC.

Transplantation. 2017 Sep;101(9):2133-2138. doi: 10.1097/TP.0000000000001549.

PMID:
27798513
21.

Analysis of diagnostic methods as a screening test to detect BK virus nephropathy in kidney transplant patients.

Nihei CH, Pierrotti LC, David-Neto E.

J Bras Nefrol. 2016 Jul-Sep;38(3):277-279. doi: 10.5935/0101-2800.20160042. English, Portuguese. No abstract available.

22.

Evaluation of MDRD4, CKD-EPI, BIS-1, and modified Cockcroft-Gault equations to estimate glomerular filtration rate in the elderly renal-transplanted recipients.

David-Neto E, Triboni AH, Ramos F, Agena F, Galante NZ, Altona M, Lemos FB, Sapienza MT, Nahas WC.

Clin Transplant. 2016 Dec;30(12):1558-1563. doi: 10.1111/ctr.12857. Epub 2016 Nov 6.

PMID:
27726196
23.

Renal transplantation in human immunodeficiency virus-infected recipients: a case-control study from the Brazilian experience.

Vicari AR, Spuldaro F, Sandes-Freitas TV, Cristelli MP, Requião-Moura LR, Reusing JO Jr, Pierrotti LC, Oliveira ML, Girão CM, Gadonski G, Kroth LV, Deboni LM, Ferreira GF, Tedesco-Silva H, Esmeraldo R, David-Neto E, Saitovitch D, Keitel E, Garcia VD, Pacheco-Silva A, Medina-Pestana JO, Manfro RC.

Transpl Infect Dis. 2016 Oct;18(5):730-740. doi: 10.1111/tid.12592. Epub 2016 Sep 26.

PMID:
27503081
24.

Longitudinal Pharmacokinetics of Tacrolimus in Elderly Compared With Younger Recipients in the First 6 Months After Renal Transplantation.

David-Neto E, Romano P, Kamada Triboni AH, Ramos F, Agena F, Almeida Rezende Ebner P, Altona M, Galante NZ, Brambate Carvalhinho Lemos F.

Transplantation. 2017 Jun;101(6):1365-1372. doi: 10.1097/TP.0000000000001369.

PMID:
27482958
25.

Outbreak of IMP-producing carbapenem-resistant Enterobacter gergoviae among kidney transplant recipients.

Freire MP, de Oliveira Garcia D, Cury AP, Spadão F, Di Gioia TS, Francisco GR, Bueno MF, Tomaz M, de Paula FJ, de Faro LB, Piovesan AC, Rossi F, Levin AS, David Neto E, Nahas WC, Pierrotti LC.

J Antimicrob Chemother. 2016 Sep;71(9):2577-85. doi: 10.1093/jac/dkw165. Epub 2016 May 19.

PMID:
27197663
26.

Pre-transplant shedding of BK virus in urine is unrelated to post-transplant viruria and viremia in kidney transplant recipients.

Bicalho CS, Oliveira RR, Pierrotti LC, Fink MC, Urbano PR, Nali LH, Luna EJ, Romano CM, David DR, David-Neto E, Pannuti CS.

Clin Transplant. 2016 Jul;30(7):796-801. doi: 10.1111/ctr.12752. Epub 2016 May 29.

PMID:
27101526
27.

Coronary Artery Disease Assessment and Intervention in Renal Transplant Patients: Analysis from the KiHeart Cohort.

De Lima JJ, Gowdak LH, de Paula FJ, Muela HC, David-Neto E, Bortolotto LA.

Transplantation. 2016 Jul;100(7):1580-7. doi: 10.1097/TP.0000000000001157.

PMID:
26982956
28.

Outcomes and Mortality in Renal Transplant Recipients Admitted to the Intensive Care Unit.

Marques ID, Caires RA, Machado DJ, Goldenstein PT, Rodrigues CE, Pegas JC, de Paula FJ, David-Neto E, Costa MC.

Transplant Proc. 2015 Nov;47(9):2694-9. doi: 10.1016/j.transproceed.2015.07.035.

PMID:
26680074
29.

New findings about trichodysplasia spinulosa-associated polyomavirus (TSPyV)--novel qPCR detects TSPyV-DNA in blood samples.

Urbano PR, Nali LH, Bicalho CS, Pierrotti LC, David-Neto E, Pannuti CS, Romano CM.

Diagn Microbiol Infect Dis. 2016 Feb;84(2):123-4. doi: 10.1016/j.diagmicrobio.2015.10.011. Epub 2015 Oct 21.

PMID:
26602950
30.

Urological complications, vesicoureteral reflux, and long-term graft survival rate after pediatric kidney transplantation.

Torricelli FC, Watanabe A, Piovesan AC, Antonopoulos IM, David-Neto E, Nahas WC.

Pediatr Transplant. 2015 Dec;19(8):844-8. doi: 10.1111/petr.12591. Epub 2015 Oct 3.

PMID:
26431694
31.

Coronary events in obese hemodialysis patients before and after renal transplantation.

De Lima JJ, Gowdak LH, de Paula FJ, Muela HC, David-Neto E, Bortolotto LA.

Clin Transplant. 2015 Nov;29(11):971-7. doi: 10.1111/ctr.12616. Epub 2015 Oct 6.

PMID:
26277344
32.

Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients.

Freire MP, Abdala E, Moura ML, de Paula FJ, Spadão F, Caiaffa-Filho HH, David-Neto E, Nahas WC, Pierrotti LC.

Infection. 2015 Jun;43(3):315-23. doi: 10.1007/s15010-015-0743-4. Epub 2015 Feb 18.

PMID:
25690848
33.

Amikacin prophylaxis and risk factors for surgical site infection after kidney transplantation.

Freire MP, Antonopoulos IM, Piovesan AC, Moura ML, de Paula FJ, Spadão F, Guimarães T, David-Neto E, Nahas WC, Pierrotti LC.

Transplantation. 2015 Mar;99(3):521-7. doi: 10.1097/TP.0000000000000381.

PMID:
25254907
34.

Dynamics of anti-human leukocyte antigen antibodies after renal transplantation and their impact on graft outcome.

de Souza PS, David-Neto E, Panajotopolous N, Agena F, Rodrigues H, Ronda C, David DR, Kalil J, Nahas WC, de Castro MC.

Clin Transplant. 2014 Nov;28(11):1234-43. doi: 10.1111/ctr.12451. Epub 2014 Sep 23.

PMID:
25142061
35.

Rituximab in a B cell-driven regimen for the treatment of recurrent membranoproliferative glomerulonephritis after kidney transplantation.

Marques ID, Ramalho J, David DR, Nahas WC, David-Neto E.

Int Urol Nephrol. 2014 Oct;46(10):2053-4. doi: 10.1007/s11255-014-0792-0. Epub 2014 Jul 31. No abstract available.

PMID:
25080208
36.

Rapid detection of trichodysplasia spinulosa-associated polyomavirus in skin biopsy specimen.

Urbano PR, Pannuti CS, Pierrotti LC, David-Neto E, Romano CM.

Genome Announc. 2014 Jul 24;2(4). pii: e00694-14. doi: 10.1128/genomeA.00694-14.

37.

Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease.

Yale JF, Bakris G, Cariou B, Nieto J, David-Neto E, Yue D, Wajs E, Figueroa K, Jiang J, Law G, Usiskin K, Meininger G; DIA3004 Study Group.

Diabetes Obes Metab. 2014 Oct;16(10):1016-27. doi: 10.1111/dom.12348. Epub 2014 Jul 22.

PMID:
24965700
38.

Current management issues of immediate postoperative care in pediatric kidney transplantation.

Torricelli FC, Watanabe A, David-Neto E, Nahas WC.

Clinics (Sao Paulo). 2014;69 Suppl 1:39-41. Review.

39.

A double-blinded, prospective study to define antigenemia and quantitative real-time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients.

David-Neto E, Triboni AH, Paula FJ, Vilas Boas LS, Machado CM, Agena F, Latif AZ, Alencar CS, Pierrotti LC, Nahas WC, Caiaffa-Filho HH, Pannuti CS.

Transplantation. 2014 Nov 27;98(10):1077-81. doi: 10.1097/TP.0000000000000189.

PMID:
24839894
40.

Pneumocystis jirovecii pneumonia with an atypical granulomatous response after kidney transplantation.

Ramalho J, Bacelar Marques ID, Aguirre AR, Pierrotti LC, de Paula FJ, Nahas WC, David-Neto E.

Transpl Infect Dis. 2014 Apr;16(2):315-9. doi: 10.1111/tid.12198. Epub 2014 Mar 13.

PMID:
24621124
41.

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.

Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB 3rd, Gibson IW, Kraus E, Liapis H, Loupy A, Nickeleit V, Randhawa P, Rodriguez ER, Rush D, Smith RN, Tan CD, Wallace WD, Mengel M; Banff meeting report writing committee.

Am J Transplant. 2014 Feb;14(2):272-83. doi: 10.1111/ajt.12590. Erratum in: Am J Transplant. 2015 Oct;15(10):2784. Rangel, Erika [corrected to Rangel, Erika B].

42.

Seroconversion of 2009 pandemic influenza A (H1N1) vaccination in kidney transplant patients and the influence of different risk factors.

Azevedo LS, Gerhard J, Miraglia JL, Precioso AR, Tavares Timenetsky MD, Agena F, Gamba C, Shikanai Yasuda MA, David-Neto E, Pierrotti L.

Transpl Infect Dis. 2013 Dec;15(6):612-8. doi: 10.1111/tid.12140. Epub 2013 Oct 18.

PMID:
24134688
43.

Rejection-triggered haemophagocytic syndrome in renal transplantation successfully treated with intravenous immunoglobulin.

Marques ID, Caires RA, de Paula FJ, Nahas WC, David-Neto E.

Clin Kidney J. 2013 Oct;6(5):530-2. doi: 10.1093/ckj/sft077. Epub 2013 Aug 1.

44.

Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease.

Yale JF, Bakris G, Cariou B, Yue D, David-Neto E, Xi L, Figueroa K, Wajs E, Usiskin K, Meininger G.

Diabetes Obes Metab. 2013 May;15(5):463-73. doi: 10.1111/dom.12090. Epub 2013 Mar 28.

45.

Clinical features and outcomes of tuberculosis in kidney transplant recipients in Brazil: a report of the last decade.

Marques ID, Azevedo LS, Pierrotti LC, Caires RA, Sato VA, Carmo LP, Ferreira GF, Gamba C, de Paula FJ, Nahas WC, David-Neto E.

Clin Transplant. 2013 Mar-Apr;27(2):E169-76. doi: 10.1111/ctr.12077. Epub 2013 Jan 28.

PMID:
23351041
46.

The perception of sleep quality in kidney transplant patients during the first year of transplantation.

Silva DS, Andrade Edos S, Elias RM, David-Neto E, Nahas WC, Castro MC, Castro MC.

Clinics (Sao Paulo). 2012 Dec;67(12):1365-71.

47.

De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.

Caires RA, Marques ID, Repizo LP, Sato VA, Carmo LP, Machado DJ, de Paula FJ, Nahas WC, David-Neto E.

Transplant Proc. 2012 Oct;44(8):2388-90. doi: 10.1016/j.transproceed.2012.07.039.

PMID:
23026601
48.

Malakoplakia after renal transplantation in the current era of immunosuppressive therapy: case report and literature review.

Leão CA, Duarte MI, Gamba C, Ramos JF, Rossi F, Galvão MM, David-Neto E, Nahas W, Shikanai-Yasuda MA, Pierrotti LC.

Transpl Infect Dis. 2012 Dec;14(6):E137-41. doi: 10.1111/tid.12012. Epub 2012 Oct 2. Review.

PMID:
23025504
49.

Diminished mycophenolic acid exposure caused by omeprazole may be clinically relevant in the first week posttransplantation.

David-Neto E, Takaki KM, Agena F, Romano P, Sumita NM, Mendes ME, Neri LA, Nahas WC.

Ther Drug Monit. 2012 Jun;34(3):331-6. doi: 10.1097/FTD.0b013e31824d6e8e.

PMID:
22549498
50.

The impact of pretransplant donor-specific antibodies on graft outcome in renal transplantation: a six-year follow-up study.

David-Neto E, Souza PS, Panajotopoulos N, Rodrigues H, Ventura CG, David DS, Lemos FB, Agena F, Nahas WC, Kalil JE, Castro MC.

Clinics (Sao Paulo). 2012;67(4):355-61.

Supplemental Content

Loading ...
Support Center